Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting

A. Aguzzi, J. Barbara, P. Brown, H. Budka, H. Diringer, D. Dormont, P. Flanagan, W. Heeschen, J. Hope, B. Hornlimann, K. Kenney, C. Masters, M. R. Macnaughton, M. Pocchiari, R. G. Rohwer, J. Safar, A. Somogyi, J. Tateishi, D. Taylor, C. M. Van DuijnJ. W. Wilesmith, R. Will, M. Wisher, D. Asher, J. De Pedro, C. Feek, K. Hasebe, F. Horaud, J. Lower, P. Minor, P. Nandapalan, A. Pavlov, A. C. Perez, M. Ricketts, G. Vicari, W. G. Van Aken, R. Beal, D. Menache-Aronson, R. Bradley, A. Bailey, H. P. Chalumeau, W. G. Van Aken, A. Garland, W. Brooks, R. Schrieber, E. Sprengers, A. G. Andjaparidze, C. L. Bolis, J. C. Emmanuel, E. Griffiths, D. L. Heymann, W. Kaboyo, F. X. Meslin, S. Miyagawa, A. P. Marroquin, A. Schudel, M. Zeidler

Research output: Contribution to journalArticlepeer-review

Abstract

The report in March 1996 of 10 human cases of a novel form of Creutzfeldt-Jakob disease in the United Kingdom, and its possible link to the agent that causes bovine spongiform encephalopathy (BSE), raises many questions about the safety of animal-derived products and by-products entering the food chain or being used in medicine. This Memorandum updates the preventive measures put forward in 1991 to minimize the risks associated with the use of bovine-derived materials in medicinal products and medical devices.

Original languageEnglish
Pages (from-to)505-513
Number of pages9
JournalBulletin of the World Health Organization
Volume75
Issue number6
Publication statusPublished - 1997

Cite this